Financials
| Commercial Trading Update | Nov. 06, 2024 |
| Posting of Annual Report and Notice of AGM | Nov. 05, 2024 |
| Full Year Results for the 12mths to 30 June 2024 | Oct. 22, 2024 |
| Trading Update | Jul. 08, 2024 |
| Trading Update | May. 13, 2024 |
| Interim Results | Mar. 28, 2024 |
| Full year results for the 12mths ended 30 Jun 2023 | Nov. 09, 2023 |
Proxies
| Results of 2024 Annual General Meeting | Nov. 29, 2024 |
| AGM Statement | Nov. 29, 2024 |
| Results of 2023 Annual General Meeting | Dec. 15, 2023 |
| AGM Statement | Dec. 15, 2023 |
| Posting of Annual Report and Notice of AGM | Nov. 20, 2023 |
| Results of 2022 Annual General Meeting | Dec. 01, 2022 |
| AGM Statement | Dec. 01, 2022 |
Ownership Update
| Holding(s) in Company | Dec. 30, 2024 |
| Holding(s) in Company | Dec. 12, 2024 |
| Notification of dealings by a director/PDMR | Dec. 09, 2024 |
| Notification of dealings by a director/PDMR | Dec. 09, 2024 |
| Grant of Options and Director Fee Shares | Dec. 09, 2024 |
| Holding(s) in Company | Aug. 20, 2024 |
| TR-1: Standard form notification of major holdings | Aug. 16, 2024 |
Announcements
| New Scientific Advisory Board Members | Dec. 06, 2024 |
| Technical Update | Dec. 05, 2024 |
| Investor Webinar | Dec. 04, 2024 |
| Agreement extended with genetic medicines customer | Nov. 07, 2024 |
| Notice of Results and Investor Presentation | Oct. 17, 2024 |
| Director Appointment | Sep. 16, 2024 |
| Aptamer extends contract with Unilever | Sep. 03, 2024 |